title: Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.
authors.affiliation: Department of Medicine, Long Island Cancer Center, SUNY Stony Brook , Stony Brook, NY 11794, USA. dgladstone@notes.cc.sunysb.edu
authors.forename: Douglas E
authors.initials: DE
authors.lastname: Gladstone
authors.forename: Marc G
authors.initials: MG
authors.lastname: Golightly
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Zamkoff
mesh_terms: D017338:Cladribine / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D017338:Cladribine; D009173:Mycophenolic Acid